Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Oramed Pharmaceuticals Company Profile (NASDAQ:ORMP)

Consensus Ratings for Oramed Pharmaceuticals (NASDAQ:ORMP) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $30.00 (339.88% upside)

Analysts' Ratings History for Oramed Pharmaceuticals (NASDAQ:ORMP)
Show:
DateFirmActionRatingPrice TargetActions
4/13/2015MLV & Co.Initiated CoverageBuy$27.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2014AegisBoost Price TargetBuy$30.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014AegisBoost Price TargetBuy$25.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2014MLV & Co.Initiated CoverageBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013Capital Ideas ResearchInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013AegisInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2013 forward)